Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month […]
Mizuho began coverage on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) in a report released on Thursday, The Fly reports. The firm issued a buy rating and a $52.00 target price on the stock. Several other analysts also recently weighed in on AMLX. HC Wainwright reissued a buy rating and issued a $50.00 target […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) had its price target raised by equities researchers at Citigroup from $32.00 to $33.00 in a report issued on Tuesday, Stock Target Advisor reports. The firm presently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 145.17% from the stock’s current price. Amylyx […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) was upgraded by analysts at Citigroup to a “buy” rating in a note issued to investors on Monday, Stock Target Advisor reports. The firm presently has a $32.00 target price on the stock. Citigroup’s price target suggests a potential upside of 160.80% from the stock’s previous close. NASDAQ:AMLX traded […]
Equities researchers at Citigroup started coverage on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) in a research report issued on Wednesday, Stock Target Advisor reports. The brokerage set a “buy” rating and a $21.00 price target on the stock. Citigroup’s target price would indicate a potential upside of 148.52% from the company’s previous close. […]